文献速递甲状腺疾病

DNA甲基化数据集Meta分析显示唐氏综合征中甲状腺发育或功能基因存在异常DNA甲基化

Meta-Analysis of DNA Methylation Datasets Shows Aberrant DNA Methylation of Thyroid Development or Function Genes in Down Syndrome.
PubMed 文献 · Thyroid · 2022-12-20

研究从四个独立Illumina芯片数据集提取252例唐氏综合征个体和519例非唐氏综合征个体的全血DNA甲基化谱,分为发现集和验证集进行表观全基因组关联分析并筛选甲状腺相关基因。发现集识别18个甲状腺相关基因的显著关联,30个显著差异甲基化位点中21个在验证集也显著。发现与验证集Meta分析检测到31个差异甲基化位点,其中27个为低甲基化且与启动子相关,低甲基化甲状腺相关差异甲基化位点的平均甲基化差异随年龄下降。结论认为唐氏综合征中先天性甲状腺功能减退和早期亚临床甲状腺功能减退并非由甲状腺相关基因差异甲基化引起,观察到的变化可能是表观遗传上调的挽救现象,但确切起源仍未知。

要点

  • 唐氏综合征中先天性甲状腺功能减退和早期亚临床甲状腺功能减退的病因仍不明确。
  • Meta分析检测到31个差异甲基化位点,其中27个为低甲基化且与启动子相关。
  • 低甲基化甲状腺相关差异甲基化位点的平均甲基化差异随年龄下降。

核心结论

  • 唐氏综合征中先天性甲状腺功能减退和早期亚临床甲状腺功能减退并非由甲状腺相关基因差异甲基化引起。
  • 观察到的甲状腺相关基因DNA甲基化变化可能是通过表观遗传上调甲状腺相关基因以改善甲状腺表型的挽救现象。
  • 唐氏综合征中先天性甲状腺功能减退和早期亚临床甲状腺功能减退的确切起源仍未知。

研究设计与样本

  • 从四个独立Illumina芯片数据集提取252例唐氏综合征个体和519例非唐氏综合征个体的全血DNA甲基化谱。
  • 数据分为发现集和验证集,采用线性回归模型进行表观全基因组关联分析,并筛选甲状腺相关基因。

主要发现

  • 发现集识别18个甲状腺相关基因的显著关联,30个显著差异甲基化位点中21个在验证集也显著。
  • 发现与验证集Meta分析检测到31个差异甲基化位点,包括29个启动子相关胞嘧啶-鸟嘌呤二核苷酸且各数据集效应方向一致,以及2个差异甲基化区域。
  • 27个差异甲基化位点为低甲基化且与启动子相关。
  • 低甲基化甲状腺相关差异甲基化位点的平均甲基化差异随年龄下降。

局限性

  • 唐氏综合征中先天性甲状腺功能减退和早期亚临床甲状腺功能减退的确切起源仍未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: In Down syndrome (DS), there is high occurrence of congenital hypothyroidism (CH) and subclinical hypothyroidism (SH) early in life. The etiology of CH and early SH in DS remains unclear. Previous research has shown genome-wide transcriptional and epigenetic alterations in DS. Thus, we hypothesized that CH and early SH could be caused by epigenetically driven transcriptional downregulation of thyroid-related genes, through promoter region hypermethylation. Methods: We extracted whole blood DNA methylation (DNAm) profiles of DS and non-DS individuals from four independent Illumina array-based datasets (252 DS individuals and 519 non-DS individuals). The data were divided into discovery and validation datasets. Epigenome-wide association analysis was performed using a linear regression model, after which we filtered results for thyroid-related genes. Results: In the discovery dataset, we identified significant associations for DS in 18 thyroid-related genes. Twenty-one of 30 significant differentially methylated positions (DMPs) were also significant in the validation dataset. A meta-analysis of the discovery and validation datasets detected 31 DMPs, including 29 promoter-associated cytosine-guanine dinucleotides (CpG) with identical direction of effect across the datasets, and two differentially methylated regions. Twenty-seven DMPs were hypomethylated and promoter associated. The mean methylation difference of hypomethylated thyroid-related DMPs decreased with age. Conclusions: Contrary to our hypothesis of generalized hypermethylation of promoter regions of thyroid-related genes-indicative of epigenetic silencing of promoters and subsequent transcriptional downregulation, causing biochemical thyroid abnormalities in DS-we found an enrichment of hypomethylated DMPs annotated to promoter regions of these genes. This suggests that CH and early SH in DS are not caused by differential methylation of thyroid-related genes. Considering that epigenetic regulation is dynamic, we hypothesize that the observed thyroid-related gene DNAm changes could be a rescue phenomenon in an attempt to ameliorate the thyroid phenotype, through epigenetic upregulation of thyroid-related genes. This hypothesis is supported by the finding of decreasing methylation difference of thyroid-related genes with age. The prevalence of early SH declines with age, so hypothetically, epigenetic upregulation of thyroid-related genes also diminishes. While this study provides interesting insights, the exact origin of CH and early SH in DS remains unknown.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Lauffer P, Zwaveling-Soonawala N, Li S, et al. Meta-Analysis of DNA Methylation Datasets Shows Aberrant DNA Methylation of Thyroid Development or Function Genes in Down Syndrome. Thyroid. 2022. PMID: 36326208. doi:10.1089/thy.2022.0320

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。